Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.
about
Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of ImmunotherapyTumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune TargetingThe Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-AnalysisPrognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysisRelevance of tumor-infiltrating lymphocytes in breast cancerCurrent Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast CancerEvolving concepts: how diet and the intestinal microbiome act as modulators of breast malignancyRegulatory T Cell Modulation by CBP/EP300 Bromodomain InhibitionTargeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer TypeClinical significance of tumor-infiltrating lymphocytes in breast cancerThe intratumoural subsite and relation of CD8(+) and FOXP3(+) T lymphocytes in colorectal cancer provide important prognostic clues.The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice.Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy.Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patientsControl of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers.Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer.Tumor secretion of CCL22 activates intratumoral Treg infiltration and is independent prognostic predictor of breast cancer.Markers of T cell infiltration and function associate with favorable outcome in vascularized high-grade serous ovarian carcinoma.The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.Clinicopathological and prognostic significance of FOXP3+ tumor infiltrating lymphocytes in patients with breast cancer: a meta-analysisPDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy.Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysis.Gastrointestinal microbiome and breast cancer: correlations, mechanisms and potential clinical implications.Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer.The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion.Targeting immunosuppression for cancer therapy.CD4⁺ follicular helper T cell infiltration predicts breast cancer survivalA prognostic risk model for patients with triple negative breast cancer based on stromal natural killer cells, tumor-associated macrophages and growth-arrest specific protein 6.Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot studyRegulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancerCrucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer.An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers.The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma.Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A meta-analysis.Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma.Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer.Adoptive immunotherapy of metastatic breast cancer: present and future.
P2860
Q26745444-C6772AB9-8EAB-4C70-8FC9-8261DC7C9E6DQ26747792-8948337B-A5AC-43CF-9486-3FB8F2BF790EQ26748691-C19DB81A-BF25-4EB3-AB3F-FE8A04BEBB66Q26783675-A25086FD-FA62-4BE0-828A-B6D13D3676C6Q26795598-C7E60A7F-C0D7-4AF2-A5AD-F77B7782B04DQ26798074-CA942687-3469-48F3-93C5-0F4807D87EEAQ27007784-72656EB5-627D-4874-98DC-386865CBEC02Q27644651-8A8CB5F4-5FD3-4AA1-88D2-0DF87F0C8B3EQ28066522-D29C6FC8-75D1-4018-8ED7-E26928FF75DDQ28070214-7EFEADFB-0B9A-4DD8-9479-54F5E3D9F476Q33613578-27032E7E-893A-42A9-B2C2-3D6121A488DFQ33660069-04827C77-0FC7-457D-8FBC-32BB9F701387Q34039445-E3F1E41F-848A-43F6-9FCF-7FE861BDD556Q34447829-33D693CA-4BEB-41F0-BFCB-1677CCBE1A60Q34538321-A9462406-F8DF-4E87-ACFF-5F55BD31CFE4Q34708248-6125D4B0-A50B-4355-811B-3BAF68FB736CQ35000238-BC9732F2-916B-44C7-AD38-EDECCC2EBE47Q35000651-814235EF-0F2F-4A83-807D-5B6A6690F0C4Q35016950-16EA1916-0EF1-4627-9885-9D1C9E7E1C9BQ35077586-1D941F6C-36A6-4042-BBC8-0E364AC37936Q35754821-9C10C996-F129-4D31-8A95-67893B957387Q35811294-D19D9C74-156E-4243-B7CB-BAF8A89A9C74Q35955369-3700D10F-3F10-4EEA-A74A-BD40F281D681Q36030405-F6192EAF-5E56-485D-8EA9-FD2A36DE647EQ36114808-52058BDB-EAAA-4D55-987D-57CDCDB01749Q36154657-EA30961A-C4DB-4B91-A321-FFE1843B4DBEQ36432125-E1051843-A799-49D1-AE3F-35B7D13AA93DQ36562375-7DC38A94-E0C6-443C-B30A-815996EB6C96Q36890918-9FA9F12E-8702-4E75-88DE-8817FF251511Q36966923-6B116139-3EB2-4A6D-8CC2-47BBBC9E4B4DQ37098286-2846139B-1BE2-4C9E-9719-3E47BBCCCC92Q37135064-1E14EE47-D83F-4017-825D-47651F5E14D3Q37222138-747E0FAA-1313-41FB-AA1B-BED4F08CEB7DQ37335249-0EA73E47-5A2B-4FA6-93B5-B6FA6C925C7AQ37470361-16D29864-099C-43E0-92CC-360FB80E9BF8Q37471704-FCC332A8-E94D-46BB-9918-AAC2E5A7478AQ37536862-CE85C4D1-9FC9-43E5-8D09-9472CC72D3C7Q37713070-397EDCDB-8305-4C46-B6DD-441BABBF1F80Q37716586-C9485647-6B38-4502-B97C-AC00A9BA9257Q38171325-22BB4AB0-05EB-4959-A2A2-77A3D1B401A9
P2860
Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Tumour-infiltrating FOXP3(+) l ...... ceptor-negative breast cancer.
@ast
Tumour-infiltrating FOXP3(+) l ...... ceptor-negative breast cancer.
@en
type
label
Tumour-infiltrating FOXP3(+) l ...... ceptor-negative breast cancer.
@ast
Tumour-infiltrating FOXP3(+) l ...... ceptor-negative breast cancer.
@en
prefLabel
Tumour-infiltrating FOXP3(+) l ...... ceptor-negative breast cancer.
@ast
Tumour-infiltrating FOXP3(+) l ...... ceptor-negative breast cancer.
@en
P2093
P2860
P50
P356
P1476
Tumour-infiltrating FOXP3(+) l ...... eceptor-negative breast cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2012.524
P407
P577
2012-11-20T00:00:00Z